Abstract
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have